Large-scale simulation of coverage and error rate tradeoffs for cancer detection in cell-free DNA whole-genome sequencing.
Blood tests detecting cancer DNA show promise for catching recurrence earlier than conventional imaging alone.
This PubMed record reports cell-free DNA (cfDNA) whole-genome sequencing (WGS) is a promising approach for detecting cancer recurrence. The study was classified as observational study and is relevant to early detection.
What the study was
- Study design
- Observational study
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Bioinformatics (Oxford, England)
Why it surfaced
Conservative triage based on the PubMed abstract, observational study, clinical relevance, and unmet-need signals.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.